Home › Alopecia Areata › California
Alopecia Areata clinical trials in California
10 studies for Alopecia Areata are looking for participants at sites in California.
Cities in California
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dermatology Research Associates - Los Angeles /ID# 282821, Los Angeles
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Oct 2, 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Center For Dermatology Clinical Research, Inc., Fremont
- Northridge Clinical Trials, Northridge
- Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita
RecruitingPhase 2
Ages 18 to 50 · All sexes · Updated Sep 22, 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Doc1 Healthcare Systems, Brea
- University of California - Irvine, Irvine
- Gavin Herbert Eye Institute, Irvine
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 18, 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- California Dermatology & Clinical Research Institute, Encinitas
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 10, 2026 · NCT07733765Dupilumab in the Treatment of Pediatric Alopecia Areata
- University of California, Irvine, Irvine
- University of California San Diego, San Diego
RecruitingPhase 2
Ages 6 to 17 · All sexes · Updated Sep 2, 2026 · NCT05866562A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Exalt Clinical Research /ID# 283814, Chula Vista
- First Oc Dermatology /ID# 259220, Fountain Valley
- Dermatology Research Associates /ID# 258033, Los Angeles
- and 3 more
RecruitingPhase 3
Ages 12 to 63 · All sexes · Updated Aug 3, 2026 · NCT06012240Regeneron AA Multicenter (Dupilumab)
- University of California, Irvine, Irvine
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT05551793A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- California Dermatology & Clinical Research Institute, Encinitas
RecruitingPhase 3
Ages 6 to 14 · All sexes · Updated Apr 28, 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Clinical Trial Research Institute, Thousand Oaks
RecruitingPhase 1/2
Ages 18 to 55 · All sexes · Updated Mar 4, 2026 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Kern Research Inc., Bakersfield
- Center For Dermatology Clinical Research Inc., Fremont
- Dermatology Research Associates, Los Angeles
- and 2 more
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Jan 28, 2026 · NCT07133308From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.